AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from the ...
The Federal Reserve now expects no reduction in its policy rate in 2026, according to the Summary of Economic Projections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results